GlassScriptPhysician profile
Maureen E Sampson
NPI 1164691085
$985.32
in general payments reported to CMS, 2019-2025
20 companies · $328 in 2025
The $328 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.31 · 2020: $97.45 · 2022: $84.83 · 2023: $133 · 2024: $329 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $789.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $231.28 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Abbvie INC. | $100.18 | 2022-2025 | Ubrelvy |
| Pfizer INC. | $98.94 | 2024-2025 | |
| Lilly USA, LLC | $79.31 | 2020-2025 | Mounjaro, Zepbound |
| Abbott Laboratories | $69.70 | 2022-2025 | Freestyle Libre 3 |
| Corium, LLC | $60.74 | 2023-2024 | Azstarys |
| Allergan, INC. | $43.18 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $41.64 | 2020-2025 | Airsupra |
| Glaxosmithkline, LLC. | $33.70 | 2020-2023 | Shingrix |
| Hologic Sales and Service, LLC | $33.08 | 2022-2024 | Aptima |
| Merck Sharp & Dohme LLC | $30.01 | 2024 | Gardasil 9, Gardasil, Vaxelis |
| Cranial Technologies, INC | $27.88 | 2024 | Doc Band |
| Regeneron Healthcare Solutions, INC. | $24.07 | 2025 | Evkeeza |
| Axsome Therapeutics, INC. | $19.81 | 2025 | Symbravo |
| Astellas Pharma US INC | $18.47 | 2024 | Veozah |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $17.77 | 2024 | Dexcom G6 Transmitter |
| Idorsia Pharmaceuticals US INC | $15.94 | 2023 | Quviviq |
| Phathom Pharmaceuticals, INC. | $14.34 | 2025 | Voquezna |
| Ironshore Pharmaceuticals INC. | $13.31 | 2019 | |
| Dynavax Technologies Corporation | $11.97 | 2024 | Heplisav-B |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maureen Sampson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.